Find Ceftolozane Sulfate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

FDF

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

5 RELATED EXCIPIENT COMPANIES

4EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 936111-69-2, Cxa-101, Ceftolozane sulfate [usan], 7r247u84hy, Fr264205, Fr-264205
Molecular Formula
C23H32N12O12S3
Molecular Weight
764.8  g/mol
InChI Key
UJDQGRLTPBVSFN-TVNHLQOTSA-N
FDA UNII
7R247U84HY

Ceftolozane Sulfate
1 2D Structure

Ceftolozane Sulfate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(6R,7R)-3-[[3-amino-4-(2-aminoethylcarbamoylamino)-2-methylpyrazol-1-ium-1-yl]methyl]-7-[[(2Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrogen sulfate
2.1.2 InChI
InChI=1S/C23H30N12O8S2.H2O4S/c1-23(2,20(40)41)43-31-11(15-30-21(26)45-32-15)16(36)29-12-17(37)35-13(19(38)39)9(8-44-18(12)35)6-34-7-10(14(25)33(34)3)28-22(42)27-5-4-24;1-5(2,3)4/h7,12,18,25H,4-6,8,24H2,1-3H3,(H7,26,27,28,29,30,32,36,38,39,40,41,42);(H2,1,2,3,4)/b31-11-;/t12-,18-;/m1./s1
2.1.3 InChI Key
UJDQGRLTPBVSFN-TVNHLQOTSA-N
2.1.4 Canonical SMILES
CC(C)(C(=O)O)ON=C(C1=NSC(=N1)N)C(=O)NC2C3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)O.OS(=O)(=O)[O-]
2.1.5 Isomeric SMILES
CC(C)(C(=O)O)O/N=C(/C1=NSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC(=C(N4C)N)NC(=O)NCCN)C(=O)O.OS(=O)(=O)[O-]
2.2 Other Identifiers
2.2.1 UNII
7R247U84HY
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ceftolozane

2. Cxa-101

3. Fr 264205

4. Fr-264205

5. Fr26 4205

6. Fr264205

2.3.2 Depositor-Supplied Synonyms

1. 936111-69-2

2. Cxa-101

3. Ceftolozane Sulfate [usan]

4. 7r247u84hy

5. Fr264205

6. Fr-264205

7. Ceftolozane

8. (6r,7r)-3-[[3-amino-4-(2-aminoethylcarbamoylamino)-2-methylpyrazol-1-ium-1-yl]methyl]-7-[[(2z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid;hydrogen Sulfate

9. Cxa-101 (for Sulfate)

10. Unii-7r247u84hy

11. Cxa 101

12. Fr 264205

13. Ceftolozane Sulfate [mi]

14. Ceftolozane Sulfate (jan/usan)

15. Ceftolozane Sulfate [jan]

16. Cxa-301

17. Dtxsid001027693

18. Ceftolozane Sulfate [vandf]

19. Ex-a4483

20. Ceftolozane Sulfate [who-dd]

21. Ceftolozane Sulfate [orange Book]

22. Ac-36560

23. Zerbaxa Component Ceftolozane Sulfate

24. Ceftolozane Sulfate Component Of Zerbaxa

25. D10098

26. 1h-pyrazolium, 5-amino-4-((((2-aminoethyl)amino)carbonyl)amino)-2-(((6r,7r)-7-(((2z)- 2-(5-amino-1,2,4-thiadiazol-3-yl)-2-((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2- Carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, Sulfate (1:1)

27. 5-amino-4-(((2-aminoethyl)carbamoyl)amino)-2-(((6r,7r)-7-(((2z)-2-(5-amino-1,2,4- Thiadiazol-3-yl)-2-((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5- Thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-1h-pyrazolium Monosulfate

28. 5-amino-4-(((2-aminoethyl)carbamoyl)amino)-2-(((6r,7r)-7-(((2z)-2-(5-amino-1,2,4- Thiadiazol-3-yl)-2-((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-1h-pyrazolium Monosulfate

2.4 Create Date
2011-06-02
3 Chemical and Physical Properties
Molecular Weight 764.8 g/mol
Molecular Formula C23H32N12O12S3
Hydrogen Bond Donor Count9
Hydrogen Bond Acceptor Count20
Rotatable Bond Count12
Exact Mass764.14247802 g/mol
Monoisotopic Mass764.14247802 g/mol
Topological Polar Surface Area439 Ų
Heavy Atom Count50
Formal Charge0
Complexity1360
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Anti-Bacterial Agents

Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)


API SUPPLIERS

read-more
read-more

01

Jinan Tantu Chemicals

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Jinan Tantu Chemicals

02

Molcore

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

Duphat
Not Confirmed
arrow

Molcore

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

arrow
Duphat
Not Confirmed
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothJinan Tantu Chemicals offers customized R&D services & production of small molecule APIs & pharmaceutical intermediates.

Flag China
Digital Content Digital Content

Ceftolozane Sulfate

About the Company : Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include c...

Jinan Tantu Chemicals Co., Ltd. operates as a Contract Development and Manufacturing Organization (CDMO) that serves pharmaceutical companies worldwide. Our core services include customized R&D as well as the production of small molecule pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs) for both international and domestic pharmaceutical firms. Our capabilities span from laboratory-scale kilograms to commercial ton-scale production. Additionally, we are committed to independent research and development, as well as the production and sales of high-end pharmaceutical intermediates and API products.
Jinan Tantu Chemicals

02

Molcore

China
PharmaVenue
Not Confirmed
arrow

Molcore

China
arrow
PharmaVenue
Not Confirmed

Ceftolozane Sulfate

About the Company : MolCore specialized in the developing, production and marketing of the raw material for medicine, pharmaceutical intermediates, and fine chemical products. Now our main business sc...

MolCore specialized in the developing, production and marketing of the raw material for medicine, pharmaceutical intermediates, and fine chemical products. Now our main business scope includes CRO, CDMO, process development and customized synthesis service. Our mission is to accelerate for your process through our continuous technological innovation. We have professional team with young, experienced and enthusiasm members, who are the great talents in this industry. We are also equipped with advanced experimental facilities as well as leading developing technology of the new medicine.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

APIs

read-more
read-more
PharmaCompass
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

read-more
read-more

01

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 8968753

Drug Substance Claim :

Drug Product Claim :

Application Number : 206829

Patent Use Code : U-1673

Delist Requested :

Patent Use Description : TREATMENT OF COMPLICAT...

Patent Expiration Date : 2034-03-14

blank

02

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 9320740

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206829

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

03

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 7129232

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206829

Patent Use Code : U-3360

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-05-15

blank

04

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 10933053

Drug Substance Claim :

Drug Product Claim :

Application Number : 206829

Patent Use Code : U-3091

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-09-09

blank

05

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 8968753

Drug Substance Claim :

Drug Product Claim :

Application Number : 206829

Patent Use Code : U-1672

Delist Requested :

Patent Use Description : TREATMENT OF COMPLICAT...

Patent Expiration Date : 2034-03-14

blank

06

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 10420841

Drug Substance Claim :

Drug Product Claim :

Application Number : 206829

Patent Use Code : U-3360

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

07

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 10420841

Drug Substance Claim :

Drug Product Claim :

Application Number : 206829

Patent Use Code : U-2631

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-03-14

blank

08

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 8685957

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206829

Patent Use Code : U-36

Delist Requested :

Patent Use Description : METHODS OF TREATING BA...

Patent Expiration Date : 2032-09-27

blank

09

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 8476425

Drug Substance Claim : Y

Drug Product Claim :

Application Number : 206829

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-09-27

blank

10

arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CUBIST PHARMS LLC

Switzerland
arrow
Pharma, Lab & Chemical Expo
Not Confirmed

CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM

US Patent Number : 7129232

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 206829

Patent Use Code : U-3361

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-05-15

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Ceftolozane Sulfate Manufacturers

A Ceftolozane Sulfate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ceftolozane Sulfate, including repackagers and relabelers. The FDA regulates Ceftolozane Sulfate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ceftolozane Sulfate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ceftolozane Sulfate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ceftolozane Sulfate Suppliers

A Ceftolozane Sulfate supplier is an individual or a company that provides Ceftolozane Sulfate active pharmaceutical ingredient (API) or Ceftolozane Sulfate finished formulations upon request. The Ceftolozane Sulfate suppliers may include Ceftolozane Sulfate API manufacturers, exporters, distributors and traders.

click here to find a list of Ceftolozane Sulfate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ceftolozane Sulfate NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ceftolozane Sulfate as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Ceftolozane Sulfate API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Ceftolozane Sulfate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Ceftolozane Sulfate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ceftolozane Sulfate NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Ceftolozane Sulfate suppliers with NDC on PharmaCompass.

Ceftolozane Sulfate GMP

Ceftolozane Sulfate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Ceftolozane Sulfate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ceftolozane Sulfate GMP manufacturer or Ceftolozane Sulfate GMP API supplier for your needs.

Ceftolozane Sulfate CoA

A Ceftolozane Sulfate CoA (Certificate of Analysis) is a formal document that attests to Ceftolozane Sulfate's compliance with Ceftolozane Sulfate specifications and serves as a tool for batch-level quality control.

Ceftolozane Sulfate CoA mostly includes findings from lab analyses of a specific batch. For each Ceftolozane Sulfate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Ceftolozane Sulfate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ceftolozane Sulfate EP), Ceftolozane Sulfate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ceftolozane Sulfate USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty